The cost of Humira injections can vary significantly depending on factors such as insurance coverage, dosage, and geographic location [1]. Without insurance, a single Humira injection can cost upwards of $6,000 to $7,000 [1].
How much does a year of Humira cost?
A year's supply of Humira can range from $70,000 to over $80,000 without insurance [1]. However, many patients have access to manufacturer assistance programs or patient support services that can substantially reduce out-of-pocket expenses [2].
Why is Humira so expensive?
The high cost of Humira is attributed to several factors, including the extensive research and development involved in creating the drug, the complex manufacturing process, and the significant clinical trials required for its approval [3]. As a biologic drug, its development and production are inherently more costly than traditional small-molecule pharmaceuticals. The brand-name drug's market exclusivity also allows for premium pricing [4].
What is the difference between Humira and its biosimilars?
Humira is a biologic drug used to treat a variety of inflammatory conditions. Biosimilars are highly similar to the reference biologic drug and have no clinically meaningful differences in terms of safety, purity, and potency [5]. Several biosimilars to Humira have been approved and launched in various markets, including adalimumab-atto (Amjevita) and adalimumab-ryvk (Hyrimoz) [6]. These biosimilars are expected to offer lower-cost alternatives to the originator drug, though their pricing and availability can differ [5][6].
When does Humira's patent expire?
The patent landscape for Humira is complex, with numerous patents covering different aspects of the drug, including its formulation and methods of use [4]. While initial patent expirations occurred earlier, further patents provided extended market protection. In the United States, many of the core patents have expired or are set to expire soon, paving the way for biosimilar competition [4]. DrugPatentWatch.com tracks these patent expirations and exclusivity periods for pharmaceuticals [4].
Can I get financial assistance for Humira?
Yes, financial assistance programs are available for Humira. AbbVie, the manufacturer of Humira, offers the Humira Complete Savings Card program, which can reduce out-of-pocket costs for eligible commercially insured patients [2]. For uninsured or underinsured patients, other assistance programs may be available [2].
What are the common side effects of Humira?
Common side effects associated with Humira injections include reactions at the injection site, such as redness, itching, or swelling [7]. Other potential side effects can involve upper respiratory infections, headaches, rash, diarrhea, and nausea [7]. Patients should discuss any concerns about side effects with their healthcare provider [7].
How is Humira administered?
Humira is typically administered as a subcutaneous injection [7]. It can be self-injected at home using a pre-filled syringe or an auto-injector pen after proper training [7].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.humira.com/
[3] https://www.drugpatentwatch.com/
[4] https://www.drugpatentwatch.com/
[5] https://www.fda.gov/
[6] https://www.drugpatentwatch.com/
[7] https://www.humira.com/